- Home
- WRAP vs GNLX Comparison
WRAP vs GNLX Comparison
Compare WRAP & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRAP
- GNLX
- Stock Information
- Founded
- WRAP 2016
- GNLX 2001
- Country
- WRAP United States
- GNLX United States
- Employees
- WRAP N/A
- GNLX N/A
- Industry
- WRAP Ordnance And Accessories
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- WRAP Industrials
- GNLX Health Care
- Exchange
- WRAP Nasdaq
- GNLX Nasdaq
- Market Cap
- WRAP 73.3M
- GNLX 110.9M
- IPO Year
- WRAP N/A
- GNLX 2023
- Fundamental
- Price
- WRAP $1.53
- GNLX $3.09
- Analyst Decision
- WRAP
- GNLX Strong Buy
- Analyst Count
- WRAP 0
- GNLX 4
- Target Price
- WRAP N/A
- GNLX $17.75
- AVG Volume (30 Days)
- WRAP 215.1K
- GNLX 137.5K
- Earning Date
- WRAP 05-15-2025
- GNLX 08-13-2025
- Dividend Yield
- WRAP N/A
- GNLX N/A
- EPS Growth
- WRAP N/A
- GNLX N/A
- EPS
- WRAP N/A
- GNLX N/A
- Revenue
- WRAP $3,796,000.00
- GNLX N/A
- Revenue This Year
- WRAP N/A
- GNLX N/A
- Revenue Next Year
- WRAP N/A
- GNLX N/A
- P/E Ratio
- WRAP N/A
- GNLX N/A
- Revenue Growth
- WRAP N/A
- GNLX N/A
- 52 Week Low
- WRAP $1.30
- GNLX $1.60
- 52 Week High
- WRAP $2.58
- GNLX $5.89
- Technical
- Relative Strength Index (RSI)
- WRAP 50.73
- GNLX 56.10
- Support Level
- WRAP $1.51
- GNLX $2.75
- Resistance Level
- WRAP $1.59
- GNLX $3.17
- Average True Range (ATR)
- WRAP 0.09
- GNLX 0.23
- MACD
- WRAP -0.00
- GNLX -0.00
- Stochastic Oscillator
- WRAP 23.44
- GNLX 56.94
About WRAP Wrap Technologies Inc.
Wrap Technologies Inc is a public safety technology and services company that delivers safe and effective policing solutions to law enforcement and security personnel worldwide. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.